Increased immunogenicity of surviving tumor cells enables cooperation between liposomal doxorubicin and IL-18

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1479-5876
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Increased immunogenicity of surviving tumor cells enables cooperation between liposomal doxorubicin and IL-18 ; volume:7 ; number:1 ; day:10 ; month:12 ; year:2009 ; pages:1-9 ; date:12.2009
Journal of translational medicine ; 7, Heft 1 (10.12.2009), 1-9, 12.2009

Creator
Alagkiozidis, Ioannis
Contributor
Facciabene, Andrea
Carpenito, Carmine
Benencia, Fabian
Jonak, Zdenka
Adams, Sarah
Carroll, Richard G.
Gimotty, Phyllis A.
Hammond, Rachel
Danet-Desnoyers, Gwen-äel
June, Carl H.
Powell, Daniel J.
Coukos, George
SpringerLink (Online service)

DOI
10.1186/1479-5876-7-104
URN
urn:nbn:de:1111-2016041433641
Rights
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:49 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Alagkiozidis, Ioannis
  • Facciabene, Andrea
  • Carpenito, Carmine
  • Benencia, Fabian
  • Jonak, Zdenka
  • Adams, Sarah
  • Carroll, Richard G.
  • Gimotty, Phyllis A.
  • Hammond, Rachel
  • Danet-Desnoyers, Gwen-äel
  • June, Carl H.
  • Powell, Daniel J.
  • Coukos, George
  • SpringerLink (Online service)

Other Objects (12)

Kupffer cells determine intrahepatic traffic of PEGylated liposomal doxorubicin

Kupffer cells determine intrahepatic traffic of PEGylated liposomal doxorubicin

Pegylated liposomal doxorubicin in patients with epithelial ovarian cancer

Pegylated liposomal doxorubicin in patients with epithelial ovarian cancer

Liposomal doxorubicin improves radiotherapy response in hypoxic prostate cancer xenografts

Liposomal doxorubicin improves radiotherapy response in hypoxic prostate cancer xenografts

Long-term cure of soft tissue sarcoma with pegylated-liposomal doxorubicin after doxorubicin and ifosfamide failure

Long-term cure of soft tissue sarcoma with pegylated-liposomal doxorubicin after doxorubicin and ifosfamide failure

Development and characterization of CD22-targeted pegylated-liposomal doxorubicin (IL-PLD)

Development and characterization of CD22-targeted pegylated-liposomal doxorubicin (IL-PLD)

Tierexperimentelle Untersuchung an der Ratte : die Wirkung von Doxorubicin und liposomal verkapseltem Doxorubicin auf Immunsystem und Metastasenbildung

Hochschulschrift

Tierexperimentelle Untersuchung an der Ratte : die Wirkung von Doxorubicin und liposomal verkapseltem Doxorubicin auf Immunsystem und Metastasenbildung

Randomized phase II study of the PDGFRα antibody olaratumab plus liposomal doxorubicin versus liposomal doxorubicin alone in patients with platinum-refractory or platinum-resistant advanced ovarian cancer

Randomized phase II study of the PDGFRα antibody olaratumab plus liposomal doxorubicin versus liposomal doxorubicin alone in patients with platinum-refractory or platinum-resistant advanced ovarian cancer

A multicentric observational trial of pegylated liposomal doxorubicin for metastatic breast cancer

A multicentric observational trial of pegylated liposomal doxorubicin for metastatic breast cancer

Doxorubicin and CpG loaded liposomal spherical nucleic acid for enhanced Cancer treatment

Doxorubicin and CpG loaded liposomal spherical nucleic acid for enhanced Cancer treatment

Surviving

Artikel

Surviving

Population pharmacokinetics of TLD-1, a novel liposomal doxorubicin, in a phase I trial

Population pharmacokinetics of TLD-1, a novel liposomal doxorubicin, in a phase I trial

Comparison of safety and toxicity of liposomal doxorubicin vs. conventional anthracyclines: a meta-analysis

Comparison of safety and toxicity of liposomal doxorubicin vs. conventional anthracyclines: a meta-analysis

Related objects